The Latest Updates on Stem Cell Therapy and COVID-19
A new study published by the Journal on Aging & Disease reports that intravenous administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with coronavirus disease (COVID-19) resulted in improved functional outcomes (Leng et al., Aging Dis, 11:216-228, 2020). This study demonstrated that intravenous infusion of MSCs is a safe and effective approach for […]